Diabetes mellitus in domestic cats: clinical cases from veterinary practice
DOI:
https://doi.org/10.15587/2519-8025.2022.266536Keywords:
cats, diabetes mellitus, insulin therapy, caninsulin, lantusAbstract
The aim: to analyze clinical cases of diabetes mellitus in cats and establish the effectiveness of clinical and laboratory research and treatment of animals with the help of insulin therapy.
Materials and methods. The material for the study were domestic cats admitted to the veterinary medicine clinic "Doctor Vet" (Lviv).
Results. Clinical case 1. Cat Bonya, age 10 years, body weight 4 kg. symptoms: polyuria/polydipsia and weight loss. Examination: cachexia, weakness, pale mucous membranes, unsteady gait. Blood glucose - 20.4 mmol/l, urine analysis - pH=6.0, glucose ++++, no ketones detected. Diagnosis: diabetes. For glycemic control - caninsulin at 0.25 IU/kg every 12 hours. After the start of insulin therapy, the animal's condition improved, after 2 months - an attack of hypoglycemia, blood glucose 3.0 mmol/l. The introduction of insulin was stopped for 10 days, after 10 days the cat's appetite is normal, polyuria and polydipsia are not observed, body weight gain is 300 g, blood glucose without insulin therapy is 8.0 mmol/l.
Clinical case 2. Cat Eva, age 12 years, body weight 6.7 kg, symptoms: polyuria/polydipsia during the last two weeks, increased appetite, diet - raw meat, meatballs, buckwheat porridge, boiled carrots, beets. Blood glucose 22.9 mmol/l, urine analysis – pH = 6.0, glucose ++++, ketones +. Diagnosis: diabetes. Treatment: Lantus 2 IU subcutaneously every 12 hours. After the start of insulin therapy, the condition improved, after 2 months, blood glucose was 9.00 - 13.0 mmol/l; 15.00 – 8.0 mmol/l, 21.00 – 12.0 mmol/l, glucose and ketones are absent in the urine.
Conclusions. In the first clinical case, the cat there was a decrease in demand in insulin “Caninsulin” on the background of insulin therapy. In the second clinical case, insulin therapy with the help of "Lantus" insulin allows you to reach a level of glycemia at which diabetes stops progressing, the clinical condition of the animal normalizes, which indicates the effectiveness of the prescribed treatment. Thus, we can say that diabetes in small domestic animals is a rather severe endocrine pathology, which has typical clinical and laboratory symptoms and can be successfully treated with the help of a complex medical and diagnostic approach, based on insulin therapy
References
- Gottlieb, S., Rand, J. (2018). Managing feline diabetes: current perspectives. Veterinary Medicine: Research and Reports, 9, 33–42. doi: https://doi.org/10.2147/vmrr.s125619
- Rend, D., Marshall, R. (2005). Ponimanie sakharnogo diabeta u koshek: patogenez i kontrol. Waltham Focus, 15 (3), 5–11.
- Gildikov, D. I., Baimatov, V. N. (2009). Izmeneniia belkovogo obmena pri sakharnom diabete u sobak i koshek. Rossiiskii veterinarnyi zhurnal, 4, 7–9.
- Gildikov, D. I., Baimatov, V. N. (2010). Morfofunktcionalnye izmeneniia u sobak i koshek pri sakharnom diabete. Uchenye zapiski Kazanskoi gosudarstvennoi akademii veterinarnoi meditciny im. N. E. Baumana, 201–205.
- Öhlund, M., Palmgren, M., Holst, B. S. (2018). Overweight in adult cats: a cross-sectional study. Acta Veterinaria Scandinavica, 60 (1). doi: https://doi.org/10.1186/s13028-018-0359-7
- Strage, E. M., Ley, C. J., Forkman, J., Öhlund, M., Stadig, S., Bergh, A., Ley, C. (2021). Homeostasis model assessment, serum insulin and their relation to body fat in cats. BMC Veterinary Research, 17 (1). doi: https://doi.org/10.1186/s12917-020-02729-1
- Clark, M., Hoenig, M. (2021). Feline comorbidities: Pathophysiology and management of the obese diabetic cat. Journal of Feline Medicine and Surgery, 23 (7), 639–648. doi: https://doi.org/10.1177/1098612x211021540
- Burzh, V. (2005). Sakharnyi diabet koshek: kontrol posredstvom diety / Waltham Focus, 15 (3), 36–40.
- Linari, G., Fleeman, L., Gilor, C., Giacomelli, L., Fracassi, F. (2021). Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus. Journal of Feline Medicine and Surgery, 24 (2), 168–176. doi: https://doi.org/10.1177/1098612x211013018
- Gostelow, R., Hazuchova, K., Scudder, C., Forcada, Y., Church, D., Niessen, S. J. (2017). Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin. Journal of Feline Medicine and Surgery, 20 (2), 114–121. doi: https://doi.org/10.1177/1098612x17697482
- Zeugswetter, F. K., Luckschander‐Zeller, N., Karlovits, S., Rand, J. S. (2021). Glargine versus regular insulin protocol in feline diabetic ketoacidosis. Journal of Veterinary Emergency and Critical Care, 31 (4), 459–468. doi: https://doi.org/10.1111/vec.13062
- Malerba, E., Mazzarino, M., Del Baldo, F., Corradini, S., Carotenuto, G., Giunti, M., Fracassi, F. (2018). Use of lispro insulin for treatment of diabetic ketoacidosis in cats. Journal of Feline Medicine and Surgery, 21 (2), 115–123. doi: https://doi.org/10.1177/1098612x18761696
- Saini, N. K., Wasik, B., Pires, J., Leale, D. M., Quach, N., Culp, W. T. N. et. al. (2021). Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats. Domestic Animal Endocrinology, 75, 106595. doi: https://doi.org/10.1016/j.domaniend.2020.106595
- Ahuja, R. P., Fletcher, J. M., Granger, L. A., Liu, C. C., Miessler, B., Mitchell, M. A. (2022). Changes in glucose tolerance and insulin secretion in a cohort of cats with chronic obesity. Canadian Journal of Veterinary Research, 86 (3), 181–187.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Dmytro Morozenko, Yevheniia Vashchyk, Andriy Zakhariev, Nataliia Seliukova, Dmytro Berezhnyi, Kateryna Gliebova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
